What's the Cost of Alzheimer's disease Diagnosis and Treatment in Republic of Korea?
| Republic of Korea | Turkey | Austria | |
|---|---|---|---|
| Stem cell therapy for Alzheimer's disease | from $32,900 | from $11,900 | ≈ $9,500 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Alzheimer's disease treatment and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Alzheimer's disease treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Alzheimer's disease treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Alzheimer's disease Treatment Centers in Republic of Korea: 8 Verified Options and Prices
RE:YOUTH (YONSEI BH Arterial Stemcell Clinic)
Byung-hee Lee



Get a Medical Assessment for Alzheimer's disease in Republic of Korea: Consult with Experienced Doctors Now
View all Doctors
Byung-hee Lee
900+ procedures performed over 42 years – Byung-hee Lee specializes in Alzheimer's disease with a focus on interventional neurology.
- Founding member of the Korean Stroke Society
- Regular member of the American Stroke Association
- Presented 24 SCI papers and 50 conference lectures

Kyoung Heo
The doctor is a leading neurologist in South Korea, specializing in epilepsy treatment. Currently, the doctor serves as the Head of the Neurology Department at Yonsei Severance Hospital.
The doctor graduated from Yonsei University College of Medicine and is an active member of several professional organizations, including The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.
Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Alzheimer's disease Treatment in Republic of Korea
What is the latest Alzheimer’s drug available in South Korea?
The latest Alzheimer drug available in South Korea is Leqembi (lecanemab). The Ministry of Food and Drug Safety (MFDS) approved it in May 2024. It launched for clinical use in November 2024. This monoclonal antibody targets amyloid-beta plaques to slow cognitive decline.
- Approval status: MFDS authorized the drug for mild dementia and cognitive impairment.
- Administration method: Patients receive the treatment through intravenous infusions every two weeks.
- Eligibility criteria: Confirmation of amyloid plaques via PET scan or CSF analysis is required.
- Advanced alternatives: Clinics like RE:YOUTH also offer arterial stem cell therapy for dementia.
Bookimed Expert Insight: While major centers like Asan Medical Center and Severance Hospital offer standard drug therapies, specialty clinics are emerging with localized delivery methods. RE:YOUTH (YONSEI BH Arterial Stemcell Clinic) utilizes a unique arterial delivery technology. This targets the brain directly through the blood-brain barrier. Data shows these specialized centers often provide faster access to innovative approaches than the high-volume public hospitals.
Patient Consensus: Patients note that getting biomarker testing early is essential because PET scan schedules fill up quickly in Seoul. Many recommend checking eligibility for clinical trials at university hospitals to access newer medications before they receive full insurance coverage.
Who is eligible for new disease-modifying Alzheimer’s therapies?
Eligible patients must have mild cognitive impairment or mild dementia caused by Alzheimer’s disease. Success requires early-stage diagnosis confirmed by elevated amyloid plaques via PET scans or lumbar punctures. Candidates must maintain specific cognitive scores and have no severe vascular brain disease or anticoagulation needs.
- Cognitive scores: Most protocols require Mini-Mental State Examination (MMSE) scores between 22 and 30.
- Biomarker verification: Physicians must confirm amyloid plaque presence through PET scans or cerebrospinal fluid analysis.
- Safety screen: Patients with over four microhemorrhages on MRI are disqualified due to swelling risks.
- Drug restrictions: Individuals taking full-strength blood thinners are ineligible to prevent serious brain bleeding.
Bookimed Expert Insight: While major centers like Severance Hospital serve over 1.6 million outpatients, early intervention is vital because these drugs slow rather than reverse progression. Our data shows that top Korean clinics often prioritize patients under 65 for specialized research arms. Confirming amyloid status via PET scans at high-volume facilities like Asan Medical Center before symptoms worsen improves inclusion odds.
Patient Consensus: Patients note that testing APOE4 status privately helps avoid eligibility surprises later. Many emphasize that rural residents must travel to Seoul, as primary access to these infusions and specialized MRI monitoring remains concentrated in major capital hospitals.
How long are the wait times for a dementia specialist in Korea?
Wait times for dementia specialists in Korea typically range from 24 to 62 days at major national university hospitals. While local clinics often provide same-week appointments, top-tier centers like Seoul National University Hospital (SNUH) currently report average waits of 57 to 62 days. Patients find faster access in Seoul than rural areas.
- University hospital waits: Average outpatient delays span 35 to 62 days.
- Local clinic access: Non-emergency appointments usually take a few days.
- Specialist clinic speed: Private neurology slots often book within two weeks.
- Seoul vs regional: Rural areas may have delays reaching up to 2 months.
Bookimed Expert Insight: While major centers like Asan Medical Center serve over 11,000 outpatients daily, wait times for neurology stay manageable through digital systems. Choosing a clinic with Newsweek-ranked digital infrastructure, such as the BESTcare system at Seoul National University Bundang Hospital, often correlates with more efficient patient flow and scheduling.
Patient Consensus: Patients note that using hospital mobile apps or getting a local referral significantly speeds up the booking process in Seoul. Most report that initial specialist visits usually happen within 10 days despite the heavy volume at major hospitals.
Are any experimental treatments such as stem cell or focused-ultrasound therapy available?
Experimental treatments like arterial stem cell therapy and mesenchymal stem cell research are available in South Korea. Specialized centers use advanced delivery methods to target brain tissue directly. These therapies remain in clinical stages. Patients must verify current trial status through official medical channels.
- Arterial delivery: RE:YOUTH clinic uses interventional radiology to deliver cells directly to target organs.
- Neurological expertise: Dr. Byung-hee Lee is a founding member of the Korean Stroke Society.
- Advanced diagnostics: Top-tier centers like Severance Hospital use JCI-accredited protocols for neurological screening.
- Research volume: Leading academic institutions like SNUBH manage over 1.5 million patient visits annually.
Bookimed Expert Insight: While many facilities offer standard intravenous injections, the RE:YOUTH clinic in Cheonan differentiates itself by using an arterial delivery method. This technique aims to bypass the lungs and deliver concentrated stem cells directly to the brain via the carotid artery. This specialized approach is rare even in major medical hubs like Seoul.
Patient Consensus: Patients note it is vital to distinguish between commercial clinics and official clinical trials. Many suggest consulting neurologists at large university hospitals to find legitimate research opportunities rather than paying for unproven private treatments.
What government support exists for dementia diagnosis and care?
Government support for dementia includes diagnostic coverage through Medicare Part B and long-term care via Medicaid. Specialized programs provide care navigation, home modifications, and expedited disability benefits. Local agencies offer managed resources like meal delivery and respite grants to support caregivers and patients.
- Medicare coverage: Includes cognitive assessments during annual visits and necessary laboratory diagnostic testing.
- Medicaid assistance: Serves as the primary payer for long-term custodial nursing home care.
- Veteran benefits: Providers offer increased pensions and grants for home safety modifications.
- Expedited claims: Social Security fast-tracks benefits for patients with early-onset dementia types.
- Caregiver grants: Federal programs fund respite care to give family members necessary breaks.
Bookimed Expert Insight: While government programs provide basic care, South Korean centers like Asan Medical Center and Severance Hospital offer advanced digital monitoring. Asan Medical Center manages over 10,000 outpatients daily, indicating a high-volume system that integrates government-supported standards with advanced AI diagnostics. This scale allows for more precise staging than smaller regional clinics.
Patient Consensus: Patients note that navigating federal programs is easier with a dedicated care coordinator. Many emphasize that securing home modification grants early significantly improves daily safety and comfort.
Where can international patients find English-language support and information?
International patients find English support through dedicated international centers at JCI-accredited facilities like Severance Hospital and Asan Medical Center. These centers provide bilingual coordinators and medical interpreters. Coordination teams manage clinical appointments, travel logistics, and visa processing to ensure seamless communication for neurology patients.
- International patient centers: Specialized hospital departments manage translation, scheduling, and logistics.
- Bilingual medical staff: Large institutions like SNUBH employ board-certified specialists with international training.
- Translation technologies: Digital systems like BESTcare help doctors share medical records in English.
- Professional coordination: Dedicated clinics like RE:YOUTH provide expert medical coordination for international arrivals.
Bookimed Expert Insight: While major Seoul hospitals handle over 1,000,000 patients annually, choose centers with specific international accreditations like GHA. These facilities often have more robust English-speaking infrastructure for complex neurological cases. Smaller clinics like RE:YOUTH specialize in niche therapies and provide more personalized English coordination than general hospitals.
Patient Consensus: Patients note that while major Seoul hospitals have English signage, a bilingual companion is often essential for detailed Alzheimer's consultations. Use translation apps like Papago or Google Translate to bridge communication gaps during diagnostic evaluations and daily travel.























